Zebrafish phosvitin-derived peptide Pt5 inhibits melanogenesis via cAMP pathway

• DOI: 10.1007/s10695-016-0306-3
• Publication Date: 2017-01-27T06:45:46Z
• Authors: Yuan-Yuan Liu; Xiu-Rong Su; Shou-Sheng Liu; Shuang-Shuang Yang; Cheng-Yan Jiang; Yu Zhang; Shicui Zhang
• Keywords: Melanins; 0301 basic medicine; Cell Survival; Monophenol Monooxygenase; Zebrafish Proteins; Peptide Fragments; Recombinant Proteins; Intramolecular Oxidoreductases; Phosvitin; Mice; 03 medical and health sciences; Cell Line, Tumor; Cyclic AMP; Animals; Oxidoreductases; Signal Transduction

Zebrafish phosvitin-derived peptide Pt5, consisting of the C-terminal 55 residues of phosvitin, has been shown to have an antimicrobial-immunomodulatory activity comparable to phosvitin. Here, we showed clearly that Pt5 had the capacity to inhibit tyrosinase (TYR) activity and melanin biosynthesis, and this inhibition was independent of cell proliferation and cytotoxic effects. Incubation of fluorescein isothiocyanate (FITC)-labeled Pt5 with B16F10 melanoma cells revealed that Pt5 was localized in the cytoplasm of the cells. In addition, Pt5 inhibited the expression of TYR, tyrosinase-related protein-1 (TRP-1), tyrosinase-related protein-2 (TRP-2), and microphthalmia-associated transcription factor (MITF) in B16F10 melanoma cells and reduced the intracellular cyclic adenosine monophosphate (cAMP) concentration in the cells, but it did not affect the cellular contents of pERK1/2 and β-catenin, suggesting that Pt5 regulates melanin biosynthesis via cAMP signaling pathway rather than Wnt and MAPK pathways. Collectively, these data indicate that Pt5 has the potential to be used as a melanogenesis inhibitor in medical and cosmetic industry, a novel role ever reported.